Reinhard Dummer

108PUBLICATIONS
554CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (108)

|Sep 26, 2026
The Value of Adjuvant Radiotherapy in the Treatment of Melanoma: A Multi-Center Analysis.

|Aug 26, 2026
Management of Advanced Cutaneous Squamous Cell Carcinoma over the Last Decade: A Single-Centre Retrospective Study.

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Pageof 18

Frequent Collaborators

24 joint publications

Paolo Antonio Ascierto

23 joint publications

Mitchell Paul Levesque

17 joint publications

Egle Ramelyte

15 joint publications

Dirk Schadendorf